| Eric Lanning Laborde, MD | |
|
1514 Jefferson Highway, New Orleans, LA 70121-2429 | |
| (504) 842-4083 | |
| Not Available |
| Full Name | Eric Lanning Laborde |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 20 Years |
| Location | 1514 Jefferson Highway, New Orleans, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720278237 | NPI | - | NPPES |
| 06788030 | Medicaid | MS | |
| 1067512 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | MD.200264 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ochsner Clinic Foundation | New orleans, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ochsner Clinic Llc | 8224933619 | 2403 |
News Archive
High-density lipoprotein (HDL) is often referred to as good cholesterol: high levels of HDL are associated with lower risk of cardiovascular disease. But many clinical outcome trials for drugs that raise HDL levels have failed to show significant benefits for trial participants.
Patients with locally advanced squamous cell carcinoma of the head and neck treated with hyperfractionated radiation therapy (HFX) experienced improved local-regional control and, with patients censored at five years, improved overall survival with no increase in late toxicity, according to a study published in the May 1, 2014 edition of the International Journal of Radiation Oncology ● Biology ● Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology (ASTRO).
The prototypical member of the VEGF family of proteins, VEGF, has recently been shown to protect cells in the nervous system from death and degeneration.
PrimaHealth Credit, a new marketplace lender for elective healthcare treatments, launched today. The company is transforming how elective care providers and patients access healthcare financing by offering an easy-to-use mobile lending platform and patient friendly, non-punitive financing solutions. PrimaHealth Credit also announced the appointment of industry veteran Hugh Bleemer, the former President of ChaseHealthAdvance, as CEO.
Pfizer Inc. today announced top-line results from two randomized Phase 3 studies of the irreversible pan-HER kinase inhibitor dacomitinib in patients with advanced non-small cell lung cancer.
› Verified 3 days ago
| Entity Name | Ochsner Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538151428 PECOS PAC ID: 8224933619 Enrollment ID: O20031126000513 |
News Archive
High-density lipoprotein (HDL) is often referred to as good cholesterol: high levels of HDL are associated with lower risk of cardiovascular disease. But many clinical outcome trials for drugs that raise HDL levels have failed to show significant benefits for trial participants.
Patients with locally advanced squamous cell carcinoma of the head and neck treated with hyperfractionated radiation therapy (HFX) experienced improved local-regional control and, with patients censored at five years, improved overall survival with no increase in late toxicity, according to a study published in the May 1, 2014 edition of the International Journal of Radiation Oncology ● Biology ● Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology (ASTRO).
The prototypical member of the VEGF family of proteins, VEGF, has recently been shown to protect cells in the nervous system from death and degeneration.
PrimaHealth Credit, a new marketplace lender for elective healthcare treatments, launched today. The company is transforming how elective care providers and patients access healthcare financing by offering an easy-to-use mobile lending platform and patient friendly, non-punitive financing solutions. PrimaHealth Credit also announced the appointment of industry veteran Hugh Bleemer, the former President of ChaseHealthAdvance, as CEO.
Pfizer Inc. today announced top-line results from two randomized Phase 3 studies of the irreversible pan-HER kinase inhibitor dacomitinib in patients with advanced non-small cell lung cancer.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eric Lanning Laborde, MD 1514 Jefferson Highway, New Orleans, LA 70121 Ph: (504) 842-4000 | Eric Lanning Laborde, MD 1514 Jefferson Highway, New Orleans, LA 70121-2429 Ph: (504) 842-4083 |
News Archive
High-density lipoprotein (HDL) is often referred to as good cholesterol: high levels of HDL are associated with lower risk of cardiovascular disease. But many clinical outcome trials for drugs that raise HDL levels have failed to show significant benefits for trial participants.
Patients with locally advanced squamous cell carcinoma of the head and neck treated with hyperfractionated radiation therapy (HFX) experienced improved local-regional control and, with patients censored at five years, improved overall survival with no increase in late toxicity, according to a study published in the May 1, 2014 edition of the International Journal of Radiation Oncology ● Biology ● Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology (ASTRO).
The prototypical member of the VEGF family of proteins, VEGF, has recently been shown to protect cells in the nervous system from death and degeneration.
PrimaHealth Credit, a new marketplace lender for elective healthcare treatments, launched today. The company is transforming how elective care providers and patients access healthcare financing by offering an easy-to-use mobile lending platform and patient friendly, non-punitive financing solutions. PrimaHealth Credit also announced the appointment of industry veteran Hugh Bleemer, the former President of ChaseHealthAdvance, as CEO.
Pfizer Inc. today announced top-line results from two randomized Phase 3 studies of the irreversible pan-HER kinase inhibitor dacomitinib in patients with advanced non-small cell lung cancer.
› Verified 3 days ago
Carrie Aline Stewart, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1430 Tulane Ave, New Orleans, LA 70112 Phone: 256-658-1406 | |
Dr. Harold A Fuselier, MD Urology Medicare: Medicare Enrolled Practice Location: 2820 Napoleon Ave, Suite 890, New Orleans, LA 70115 Phone: 504-412-1366 Fax: 504-412-1367 | |
Dr. Nathan Samuel Wexler, M.D. Urology Medicare: Medicare Enrolled Practice Location: 6050 Annunciation St, New Orleans, LA 70118 Phone: 504-897-3088 Fax: 504-891-1326 | |
Dr. David C Benson, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2000 Canal St Fl 5, New Orleans, LA 70112 Phone: 504-702-4333 | |
Dr. Raju Thomas, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1415 Tulane Ave, Urology Clinic, New Orleans, LA 70112 Phone: 504-988-2300 Fax: 504-988-7655 | |
Louis Spencer Krane, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1430 Tulane Ave, New Orleans, LA 70112 Phone: 504-988-2750 | |
Dr. Aaron D Martin, M.D., M.P.H Urology Medicare: Accepting Medicare Assignments Practice Location: 200 Henry Clay Ave, New Orleans, LA 70118 Phone: 504-896-9233 Fax: 504-896-9861 |